Physician profile
Jeffrey Wei
NPI 1487016952
$1,370.89
in general payments reported to CMS, 2019-2025
5 companies · $682 in 2025
The $682 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $109 · 2024: $429 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089 · Education: $66.55 · Long Term Medical Supply Or Device Loan: $64.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.60 |
| Education | $66.55 |
| Long Term Medical Supply Or Device Loan | $64.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $662.57 | 2022-2025 | Wegovy, Ozempic |
| Amgen INC. | $488.74 | 2024-2025 | Tepezza, Evenity |
| Abbott Laboratories | $140.29 | 2024 | Freestyle Libre 3, Freestyle Copilot, Freestyle Insulinx |
| Lilly USA, LLC | $56.12 | 2024-2025 | Jardiance |
| Almatica Pharma LLC | $23.17 | 2025 | Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.